| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*Both authors contributed equally to this work and are listed alphabetically.
From the Department of Neurology, Baylor College of Medicine, Houston, TX.
Address correspondence and reprint requests to Dr. Stanley H. Appel, Professor and Chairman, Department of Neurology, Baylor College of Medicine, 6501 Fannin St. NB 302, Houston, TX 77030; e-mail: sappel{at}bcm.tmc.edu
Objective: The cause of motor neuron death in ALS is incompletely understood. This study aims to define the potential involvement of nonneuronal immune-inflammatory factors in the destruction of motor neurons in mutant superoxide dismutase-1 (SOD1) transgenic mice as a model of ALS. Background: The presence of activated microglia, IgG and its receptor for Fc portion (Fc
RI), and T lymphocytes in the spinal cord of both patients with ALS and experimental animal models of motor neuron disease strongly suggests that immune-inflammatory factors may be actively involved in the disease process. Methods: The expression of immune-inflammatory factors was followed in both human mutant (G93A) SOD1 transgenic mice and human wild-type SOD1 transgenic mice, at different ages (40, 80, and 120 days). Fixed, frozen, free-floating sections of the lumbar spinal cord were stained with antibodies against CD11b, IgG, FcRI, intercellular adhesion molecule-1 (ICAM-1), CD3, and glial fibrillary acidic protein. Results: The earliest change observed was the upregulation of ICAM-1 in the ventral lumbar spinal cord of 40-day-old mutant SOD1 mice. IgG and FcRI reactivities were detected on motor neurons as early as 40 days and on microglial cells at later stages. Microglial activation was first evident in the ventral horn at 80 days, whereas reactive astrocytes and T cells became most prominent in 120-day-old mutant SOD1 mice. Conclusion: The upregulation of proinflammatory factors during early presymptomatic stages as well as the expansion of immune activation as disease progresses in mutant SOD1 transgenic mice suggest that immune-inflammatory mechanisms could contribute to disease progression.
This article has been cited by other articles:
|
|
 |
|
  I. M. Chiu, A. Chen, Y. Zheng, B. Kosaras, S. A. Tsiftsoglou, T. K. Vartanian, R. H. Brown Jr, and M. C. Carroll T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS PNAS, November 18, 2008; 105(46): 17913 - 17918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Appel, J. I. Engelhardt, J. S. Henkel, L. Siklos, D. R. Beers, A. A. Yen, E. P. Simpson, Y. Luo, G. Carrum, H. E. Heslop, et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis Neurology, October 21, 2008; 71(17): 1326 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gowing, T. Philips, B. Van Wijmeersch, J.-N. Audet, M. Dewil, L. Van Den Bosch, A. D. Billiau, W. Robberecht, and J.-P. Julien Ablation of Proliferating Microglia Does Not Affect Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase J. Neurosci., October 8, 2008; 28(41): 10234 - 10244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Beers, J. S. Henkel, W. Zhao, J. Wang, and S. H. Appel CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS PNAS, October 7, 2008; 105(40): 15558 - 15563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ahtoniemi, G. Goldsteins, V. Keksa-Goldsteine, T. Malm, K. Kanninen, A. Salminen, and J. Koistinaho Pyrrolidine Dithiocarbamate Inhibits Induction of Immunoproteasome and Decreases Survival in a Rat Model of Amyotrophic Lateral Sclerosis Mol. Pharmacol., January 1, 2007; 71(1): 30 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gowing, F. Dequen, G. Soucy, and J.-P. Julien Absence of Tumor Necrosis Factor-{alpha} Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutations. J. Neurosci., November 1, 2006; 26(44): 11397 - 11402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Beers, J. S. Henkel, Q. Xiao, W. Zhao, J. Wang, A. A. Yen, L. Siklos, S. R. McKercher, and S. H. Appel Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis PNAS, October 24, 2006; 103(43): 16021 - 16026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Boillee, K. Yamanaka, C. S. Lobsiger, N. G. Copeland, N. A. Jenkins, G. Kassiotis, G. Kollias, and D. W. Cleveland Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia. Science, June 2, 2006; 312(5778): 1389 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Bilsland, J. R. T. Dick, G. Pryce, S. Petrosino, V. Di Marzo, D. Baker, and L. Greensmith Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice FASEB J, May 1, 2006; 20(7): 1003 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. E. Perrin, G. Boisset, M. Docquier, O. Schaad, P. Descombes, and A. C. Kato No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model Hum. Mol. Genet., November 1, 2005; 14(21): 3309 - 3320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P J Shaw Molecular and cellular pathways of neurodegeneration in motor neurone disease J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1046 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. FRIEDBERG Astrocytic Activation as Evidence for Brain Damage Am J Psychiatry, January 1, 2005; 162(1): 195 - 196. [Full Text] [PDF]
|
|
|
|
|
|
J. Kirby, F. M. Menzies, M. R. Cookson, K. Bushby, and P. J. Shaw Differential gene expression in a cell culture model of SOD1-related familial motor neurone disease Hum. Mol. Genet., August 15, 2002; 11(17): 2061 - 2075. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
